155 related articles for article (PubMed ID: 37730538)
1. Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients.
Bittaye SO; Kambi A; Tekanyi MAI; Tamba S; Sanneh L; Sisawo MM; Jatta A; Fatty G; Jeng A; Jallow MS; Leigh O; Njie R
BMC Gastroenterol; 2023 Sep; 23(1):321. PubMed ID: 37730538
[TBL] [Abstract][Full Text] [Related]
2. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
3. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM
World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097
[TBL] [Abstract][Full Text] [Related]
6. Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia.
Shimakawa Y; Lemoine M; Bottomley C; Njai HF; Ndow G; Jatta A; Tamba S; Bojang L; Taal M; Nyan O; D'Alessandro U; Njie R; Thursz M; Hall AJ
Liver Int; 2015 Oct; 35(10):2318-26. PubMed ID: 25728498
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data.
Tachi K; Agyei-Nkansah A; Archampong T
Pan Afr Med J; 2020; 36():43. PubMed ID: 32774619
[TBL] [Abstract][Full Text] [Related]
8. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
9. The clinical and pathological features of hepatocellular carcinoma in Nnewi, Nigeria.
Okonkwo UC; Nwosu MN; Ukah C; Okpala OC; Ahaneku JI
Niger J Med; 2011; 20(3):366-71. PubMed ID: 21970220
[TBL] [Abstract][Full Text] [Related]
10. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
11. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Yoo S; Kim JY; Lim YS; Han S; Choi J
J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis.
Yamazaki Y; Kakizaki S; Sohara N; Sato K; Takagi H; Arai H; Abe T; Katakai K; Kojima A; Matsuzaki Y; Mori M
Dig Dis Sci; 2007 Apr; 52(4):1103-7. PubMed ID: 17380407
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
14. Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Akuta N; Suzuki F; Kobayashi M; Hara T; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
J Med Virol; 2014 Jan; 86(1):131-8. PubMed ID: 24123090
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.
Fung J; Cheung KS; Wong DK; Mak LY; To WP; Seto WK; Lai CL; Yuen MF
Hepatology; 2018 Aug; 68(2):462-472. PubMed ID: 29534307
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
17. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss.
Yip TC; Wong VW; Lai MS; Lai JC; Hui VW; Liang LY; Tse YK; Chan HL; Wong GL
J Hepatol; 2023 Mar; 78(3):524-533. PubMed ID: 36463985
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]